BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8644143)

  • 1. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
    Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
    [No Abstract]   [Full Text] [Related]  

  • 2. Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Melli C; Bruzzone P; Alfani D
    Transplant Proc; 1996 Apr; 28(2):589. PubMed ID: 8623287
    [No Abstract]   [Full Text] [Related]  

  • 3. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
    Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
    Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
    [No Abstract]   [Full Text] [Related]  

  • 4. High-level tissue specific expression of human CD59, MCP, and DAF proteins from genomic clones in transgenic mice.
    Oldham ER; Velardo MA; Platt JL; Logan JS; Diamond L
    Transplant Proc; 1996 Apr; 28(2):693. PubMed ID: 8623349
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
    Kagan D; Platt J; Logan J; Byrne GW
    Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part II: xenogeneic perfusion of the porcine liver in vivo.
    Shiraishi M; Oshiro T; Nozato E; Nagahama M; Taira K; Nomura H; Sugawa H; Muto Y
    Transpl Int; 2002 May; 15(5):212-9. PubMed ID: 12012041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
    Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1995 Feb; 27(1):317-8. PubMed ID: 7533396
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium.
    Miyagawa S; Shirakura R; Izutani H; Matsumiya G; Nakata S; Matsuda H; Iwata K; Nagasawa S; Terado A; Matsumoto M
    Transplant Proc; 1994 Jun; 26(3):1253-4. PubMed ID: 7518122
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of human DAF and MCP on pig endothelial cells protects from human complement.
    Carrington CA; Richards AC; Cozzi E; Langford G; Yannoutsos N; White DJ
    Transplant Proc; 1995 Feb; 27(1):321-3. PubMed ID: 7533398
    [No Abstract]   [Full Text] [Related]  

  • 11. Difference of expression levels between gene technological product delta CYT-MCP(CD46) and intact MCP(CD46) in transgenic mice.
    Miyagawa S; Ikawa M; Kominami K; Yoshimura Y; Tanaka H; Mikata S; Shirakura R; Matsuda H; Yanagi Y; Seya T; Okabe M
    Transplant Proc; 1996 Apr; 28(2):585-6. PubMed ID: 8623285
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of pigs transgenic for human regulators of complement activation.
    Yannoutsos N; Langford GA; Cozzi E; Lancaster R; Elsome K; Chen P; White DJ
    Transplant Proc; 1995 Feb; 27(1):324-5. PubMed ID: 7533399
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.
    Lazzeri M; Mora M; Mulder LC; Marsicano G; Marinucci G; Boschi M; Bruzzone P; Alfani D; Cortesini R; Rossini M
    J Urol; 1998 Apr; 159(4):1364-9. PubMed ID: 9507885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
    Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
    Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of human decay accelerating factor in transgenic pigs.
    Cozzi E; Langford GA; Richards A; Elsome K; Lancaster R; Chen P; Yannoutsos N; White DJ
    Transplant Proc; 1994 Jun; 26(3):1402-3. PubMed ID: 7518135
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo studies to prevent hyperacute rejection.
    Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
    Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
    Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
    Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of species-specific complement-mediated cytolysis in xenoendothelial cells transfected with GPI-anchored complement regulatory factor (DAF, HRF20) gene using retroviral vector: comparison between single (DAF or HRF20) and double (DAF and HRF20) transfected xenoendothelial cells.
    Hayashi S; Isobe K; Emi N; Yokoyama I; Takagi H
    Transplant Proc; 1994 Jun; 26(3):1243-4. PubMed ID: 7518119
    [No Abstract]   [Full Text] [Related]  

  • 20. Ex vivo perfusion of mouse hearts expressing the human complement regulatory protein CD59.
    Harland RC; Logan JS; Kooyman D; Byrne GW; Platt JL
    Transplant Proc; 1994 Jun; 26(3):1245. PubMed ID: 7518120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.